Dr Emmanuel GUARDIOLA

Diplômé de Films: « Methods in clinical cancer research » - Federation of European Cancer Societies, AACR, ASCO

Diplôme Inter Universitaire d'Anglais Médical - Université Nice-Sophia-Antipolis

Cours de chimiothérapie antitumorale et traitement médical du cancer - Centre Régional de Lutte Contre le Cancer - Institut Gustave Roussy

Docteur en Médecine - Université Nice-Sophia-Antipolis

Diplôme Universitaire de Cancérologie Médicale - Université Nice-Sophia-Antipolis

Cabinet - Montpellier

Clinique Clementville - Oncologie

Praticien hospitalier - Centre Hospitalier de la Dracénie - Draguignan - Oncologie

Praticien hospitalier - CHI de Fréjus Saint Raphaël - FREJUS - Oncologie

Praticien hospitalier - Centre Hospitalier Régional Universitaire de Besançon - Besançon - Oncologie

Coordinateur du Réseau Régional de Cancérologie de Franche Comté - Centre Hospitalier Régional Universitaire de Besançon - Besançon - Oncologie

Praticien Assistant de Centre de Lutte Contre le Cancer - Centre Antoine Lacassagne - Nice - Oncologie

Membre - European Society of Medical Oncology

Membre - Fédération Française de Cancérologie Digestive (FFCD)

Membre - Ordre National des Médecins - Médecin Spécialiste en Oncologie Médicale

Ignatiadis M, Litière S, Rothe F, Riethdorf S, Proudhon C, Fehm T, Aalders K, Forstbauer H, Fasching PA, Brain E, Vuylsteke P, Guardiola E et al. Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells. - Ann Oncol

Trédan O, Follana P, ... Guardiola E, et al.A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group - Annals of Oncology

Bouzereau V, Le Caer F, Guardiola E et al. Experience of multidisciplinary assessment of elderly patients with cancer in a French general hospital during 1 year: a new model care study - J Geriatr Oncol

Royer B...,Guardiola E et al. Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: population pharmacokinetic study. - Br J Cancer

E Guardiola et al. Intra-operative chemotherapy with cisplatin and epinephrine after cytoreductive surgery in patients with recurrent ovarian cancer. - Anti-Cancer Drugs

Joly F, Petit T, Pautier P, Guardiola E et al. Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: a French multicenter phase II study - Gynecol Oncol

E Guardiola, D Delroeux, B Heyd, M Combe, V Lorgis, M Demarchi, U Stein, B Royer, B Chauffert, X Pivot Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer - World J Surg Oncol

B Royer, Jullien V, E Guardiola et al. Population pharmacokinetics and dosing recommendations for cisplatin during intraperitoneal peroperative administration: development of a limited sampling strategy for toxicity risk assessment. - Clin Pharmacokinet

E Guardiola, F Morschhauser, J J Zambrowski, EC Antoine. Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment) - Bull Cancer

B Royer, D Delroeux, E Guardiola, M Combe, G Hoizey, JP Kantelip, B Chauffert, B Heyd, X Pivot. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer - Cancer Chemotherapy and Pharmacology

P Fagnoni, S Limat, L Chaigneau, E Guardiola, S Briaud, B Schmitt, Y Merrouche, X Pivot, MC Woronoff-Lemsi. Clinical and economic impact of epoietin in adjuvant-chemotherapy for breast cancer - Support Care Cancer

L Chaigneau, E Guardiola, T Nguyen, A Dufresne, U Stein, C Villanueva, A Thierry-Vuillemin, F Lorchel, X Pivot. Induction chemotherapy in patient with head and neck cancer. - Bull Cancer

E Guardiola, L Chaigneau, C Villanueva, X Pivot. Is there still a role for triple endoscopy as part of staging for head and neck cancer? - Curr Opin Otolaryngol Head Neck Surg

X Pivot, N Magne, E Guardiola, G Poissonnet, O Dassonville, M Francoual, JL Formento, RJ Bensadoun, F Demard, M Schneider, G Milano. Prognostic impact of the epidermal growth factor receptor levels for patients with a larynx and hypopharynx cancer - Oral Oncology

B Royer, E Guardiola, E Polycarpe, G Hoizey, D Delroeux, M Combe, L Chaigneau, E Samain, B Chauffert, B Heyd, JP Kantelip, X Pivot. Serum and intraperitoneal pharmacokinetics of cisplatin within intraoperative chemotherapy: influence of protein bindin - Anticancer Drugs

E Guardiola, X Pivot, O Dassonville, G Poissonnet, J Vallicioni, F Demard, J Otto, E François, M Poudenx, J M Ferrero, A Thyss, M Schneider. Is routine triple endoscopy for head and neck cancer patients necessary in light of a negative chest computed - Cancer

E Guardiola, F Peyrade, L Chaigneau, D Cupissol et al. Result of a randomised phase II study comparing docetaxel with methotrexate in patient with recurrent head and neck cancer. - Eur J Cancer

X Pivot, E Guardiola, U Stein. The epidermal growth factor receptor as a target for anti cancer therapy. Cancer future - Cancer future

X Pivot, E Chamorey, E Guardiola, N Magne, A Thyss, J Otto, Z Mouri, M Schneider, G Milano. Phase I and pharmacokinetic study of the association capecitabine- cisplatin in head and neck cancer patients. - Ann Oncol

Piezo-corticision using a new surgical guide : evaluation of pain and reduction of orthodontic treatment time ? X Pivot, A Awada, B Gérard, D Gedoin, J Kerger, F Rolland, D Cupissol. E Guardiola et al. Result of two randomized phase II studies comparing S - Ann Oncol

M Gainet, E Guardiola, A Dufresne, X Pivot. Les récepteurs à epidermal growth factor (REGF), une nouvelle cible thérapeutique. Cancer radiother - Cancer Radiother

Etienne MC, Leger F, Pivot X, Chatelut E, Bensadoun RJ, Guardiola E, Renée N, Magne N, Canal P, Milano G. Pharmacokinetics of low-dose carboplatin and applicability of a method of calculation for estimating individual drug clearance. - Ann Oncol

A Dufresne, M Gainet, U Stein, E Guardiola, X Pivot. Chemotherapy for patients with local-regional recurrent or metastatic carcinoma of the head and neck. - Bull Cancer

A Dufresne, E Guardiola. Follow-up of ovarian carcinoma after primary therapy. - Cancer future

N Magne, E François, L Broisin, E Guardiola et al. Palliative 5-fluorouracil-based chemotherapy for advanced colorectal cancer in the elderly: results of a 10-year experience. - Am J Clin Oncol

X Pivot, L Cals, D Cupissol, E Guardiola, X Tchicknavorian, P Guerrier, L Merad, JL Wendling, L Barnouin, J Savary, A Thyss, M Schneider. Phase II trial of Paclitaxel-Carboplatin combination in recurrent squamous cell carcinoma of the head and neck - Oncology

X Pivot, C Niyikiza, G Poissonnet, O Dassonville, R J Bensadoun, E Guardiola, C Foa, K Benezery, F Demard, A Thyss, M Schneider. Clinical prognostic factors for patients with recurrent head and neck cancer: implication for randomized trials - Oncology

N Magne, X Pivot, R J Bensadoun, E Guardiola et al. The relationship of epidermal growth factor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy. - Eur J Cancer

N Magne, X Pivot, R J Bensadoun, E Guardiola et al. The relationship of epidermal growth factor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy. - Eur J Cancer

N Magne, P Y Marcy, E Chamorey, E Guardiola, X Pivot, M Schneider, F Demard, R J Bensadoun. Concomitant twice-a-day radiotherapy and chemotherapy in unresectable head and neck cancer patients: a long-term quality of life analysis - Head and neck

E Guardiola. Traitement de l’anémie en cancérologie : transfusion ou érythropoïétine ? Oncologie - Oncologie

E Guardiola, X Pivot, X Tchiknavorian, N Magne, J Otto, A Thyss, M Schneider. Combination of cisplatin-doxorubicin-cyclophosphamide in adenocarcinoma of unknown primitive site. A phase II trial. - Am J Clin Oncol

E Guardiola, X Pivot, MC Etienne, J Otto, A Thyss, M Schneider, G Milano. An analysis of ultrafiltrable cisplatin concentration may predict the occurrence of cisplatin-related anemia in patients with head and neck cancer. - Anemia & quality of life in oncology

X Pivot, E Guardiola et al. An analysis of potential factors allowing an individual prediction of cisplatin-induced anemia. - Eur J Cancer